Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Getting Smarter about Data: New Study Uses Smartphones to Track Parkinson's

    Getting Smarter about Data: New Study Uses Smartphones to Track Parkinson's

    An observational study was launched by researchers to determine how accurately smartphones can track Parkinson's symptoms.
    Learn more
  • Redheads' Gene May Be Missing Link Between Melanoma and Parkinson's

    Redheads' Gene May Be Missing Link Between Melanoma and Parkinson's

    A new study suggests that redheads may carry a gene variant that increases the risk of both Parkinson's disease and melanoma.
    Learn more
  • Trial to Test Therapy for Excessive Daytime Sleepiness in Parkinson's Opens

    Trial to Test Therapy for Excessive Daytime Sleepiness in Parkinson's Opens

    Jazz Pharmaceuticals recently announced a Phase II trial to test a therapy for excessive daytime sleepiness in people with Parkinson's disease.
    Learn more
  • Blood Test May Help Confirm Parkinson's Diagnosis

    Blood Test May Help Confirm Parkinson's Diagnosis

    A new study suggests that evaluating levels of a certain protein in the blood may help distinguish Parkinson's from certain atypical parkinsonisms.
    Learn more
  • First Trial Begins Testing Drug in People with GBA Mutation

    First Trial Begins Testing Drug in People with GBA Mutation

    This study is a major step for PD research as it is the first drug trial where one's genetic information determines eligibility and is testing a potential therapy to slow or stop disease progress
    Learn more
  • New Dyskinesia Drug Moving Forward in Clinical Testing

    New Dyskinesia Drug Moving Forward in Clinical Testing

    MJFF funded early research of this novel drug candidate, mGluR4, helping remove financial and other barriers to advance its testing.
    Learn more
  • Inhaled Levodopa Closer to the Goal Line

    Inhaled Levodopa Closer to the Goal Line

    Pharmaceutical company Acorda reported positive results from a Phase III trial of an inhaled form of levodopa to treat "off" periods in Parkinson's.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.